Related Experiment Videos
Cardiac binding in experimental heart failure
M Vaynblat1, M Chiavarelli, H R Shah
1Division of Cardiothoracic Surgery, State University of New York-Health Science Center at Brooklyn 11203, USA.
The Annals of Thoracic Surgery
|July 1, 1997
Summary
Cardiac binding effectively prevents ventricular dilatation in heart failure models. This static cardiomyoplasty component shows promise for treating heart failure by limiting cardiac enlargement without worsening function.
Area of Science:
- Cardiovascular Research
- Surgical Innovation
- Heart Failure Therapeutics
Background:
- Cardiomyoplasty offers potential benefits for heart failure patients.
- Benefits include systolic augmentation and prevention of cardiac dilatation.
- The static component of cardiomyoplasty was investigated using an artificial membrane for cardiac binding.
Purpose of the Study:
- To evaluate the efficacy of static cardiomyoplasty in preventing cardiac dilatation.
- To assess the impact of cardiac binding on ventricular dimensions in a heart failure model.
Main Methods:
- Heart failure was induced in 10 dogs via weekly intracoronary doxorubicin administration over 4 weeks.
- Dogs were divided into two groups: no treatment and cardiac binding.
- Hemodynamic data and echocardiography were used to monitor cardiac function and dimensions.
Main Results:
- The no-treatment group showed significant increases in left and right ventricular end-diastolic pressures and diameters.
- Ejection fraction decreased in both the no-treatment and cardiac binding groups.
- No significant difference in ejection fraction decline was observed between the groups, indicating preserved ventricular function with binding.
Conclusions:
- Cardiac binding effectively reduces ventricular dilatation in a canine model of heart failure.
- This intervention does not exacerbate left ventricular dysfunction.
- Static cardiomyoplasty shows potential for managing heart failure by controlling cardiac enlargement.